Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02862288
What this trial is testing

Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.

Who this might be right for
Lung TumorBone TumorRenal Tumor
Centre Hospitalier Universitaire de Besancon 30
Testing effectiveness (Phase 2)Study completedNCT02082210
What this trial is testing

Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

Who this might be right for
Advanced CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+3 more
Eli Lilly and Company 97
Testing effectiveness (Phase 2)Ended earlyNCT02446860
What this trial is testing

Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)

Who this might be right for
Renal Cell Carcinoma
Royal Marsden NHS Foundation Trust 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Study completedNCT03207347
What this trial is testing

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Who this might be right for
MesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more
University of Florida 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03355976
What this trial is testing

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+2 more
Brown University 46
Testing effectiveness (Phase 2)Study completedNCT00276614
What this trial is testing

Bortezomib in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Jonsson Comprehensive Cancer Center 4
Not applicableLooking for participantsNCT07743749
What this trial is testing

An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors

Who this might be right for
Renal TumorKidney Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 900
Early research (Phase 1)Ended earlyNCT06336148
What this trial is testing

A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Actym Therapeutics, Inc. 10
Not applicableEnded earlyNCT01466504
What this trial is testing

Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

Who this might be right for
Renal Cell CarcinomaHepatocellular CarcinomaColorectal Carcinoma
Dartmouth-Hitchcock Medical Center 4
Testing effectiveness (Phase 2)WithdrawnNCT03540199
What this trial is testing

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Who this might be right for
Advanced Kidney Cancer
Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07346404
What this trial is testing

Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma

Who this might be right for
Renal Cell Carcinoma
Assistance Publique - Hôpitaux de Paris 50
Early research (Phase 1)Looking for participantsNCT06819293
What this trial is testing

IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Clear Renal Cell CarcinomaAdult
Grit Biotechnology 12
Not applicableLooking for participantsNCT04892849
What this trial is testing

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

Who this might be right for
HNSCCNSCLCEsophageal Cancer+4 more
University of Erlangen-Nürnberg Medical School 200
Not applicableUnknownNCT01529658
What this trial is testing

Renal Hypothermia During Partial Nephrectomy

Who this might be right for
Renal ImpairmentKidney DiseasesUrologic Diseases+3 more
Ottawa Hospital Research Institute 184
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)Study completedNCT00024258
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
Memorial Sloan Kettering Cancer Center 22
Not applicableActive Not RecruitingNCT05871008
What this trial is testing

Integrated Actionable Aging Assessment for Cancer Patients Pilot

Who this might be right for
Breast CancerHodgkin LymphomaKidney Cancer+7 more
University of Colorado, Denver 35
Early research (Phase 1)Study completedNCT03200587
What this trial is testing

Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)

Who this might be right for
Renal Cell Carcinoma
University of Utah 12
Testing effectiveness (Phase 2)Study completedNCT00035243
What this trial is testing

EPO906 Therapy in Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Neoplasms
Novartis Pharmaceuticals 53
Next Page